Loading...
Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas
Previous studies suggest that hyperprolactinaemia might have adverse effects on lipid and glucose metabolism. We therefore aimed to evaluate whether dopamine agonist treatment with cabergoline has significant effects on blood lipids, fasting glucose and HbA1c levels in patients with micro- or macrop...
Saved in:
| Published in: | Metab Brain Dis |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Springer US
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5566581/ https://ncbi.nlm.nih.gov/pubmed/27525431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-016-9882-2 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|